Zobrazeno 1 - 10
of 290
pro vyhledávání: '"AKIO MORINOBU"'
Autor:
Tsuneo Sasai, Yuki Ishikawa, Ran Nakashima, Takuya Isayama, Kiminobu Tanizawa, Tomohiro Handa, Mirei Shirakashi, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Hajime Yoshifuji, Tsuneyo Mimori, Akio Morinobu
Publikováno v:
Immunological Medicine, Vol 47, Iss 3, Pp 166-175 (2024)
Anti-aminoacyl-tRNA synthetase (ARS) antibodies are myositis-specific antibodies associated with anti-synthetase syndrome (ASSD). Some patients are positive for anti-ARS antibodies on enzyme-linked immunosorbent assay (ELISA) but negative on RNA-immu
Externí odkaz:
https://doaj.org/article/0e54cf86633747cca51432c1af8c6c16
Autor:
Koichi Murata, Ryuji Uozumi, Takayuki Fujii, Akira Onishi, Kosaku Murakami, Hideo Onizawa, Masao Tanaka, Akio Morinobu, Shuichi Matsuda
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study aims to identify factors influencing the alleviation of knee joint symptoms in patients with rheumatoid arthritis treated with biologic or target synthetic disease-modifying antirheumatic drugs (b/tsDMARDs). Among 2321 patients wh
Externí odkaz:
https://doaj.org/article/553d0e00897e414b96886daff57ca5f0
Autor:
Mirei Shirakashi, Yuri Nishida, Ran Nakashima, Masakazu Fujimoto, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Akio Morinobu, Hajime Yoshifuji
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract TAFRO syndrome is an acute systemic inflammatory disease characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and organomegaly. There have been increasing reports that TAFRO is a disease distinct from idi
Externí odkaz:
https://doaj.org/article/5e3be80b7b7f4054ab0b8fd0feb4f1c8
Autor:
Yuki Ishikawa, Hiroyuki Yoshida, Hajime Yoshifuji, Koichiro Ohmura, Tomoki Origuchi, Tomonori Ishii, Tsuneyo Mimori, Akio Morinobu, Masahiro Shiokawa, Chikashi Terao
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundIt has been well documented that Takayasu arteritis (TAK) and ulcerative colitis (UC) coexist in the same patients. HLA-B*52 characterizes the co-occurrence, which is one of the common genetic features between these two diseases, indicating
Externí odkaz:
https://doaj.org/article/c50db21bc1534d9eafe0268317222270
Autor:
Takeshi Iwasaki, Ryu Watanabe, Hiromu Ito, Takayuki Fujii, Koichiro Ohmura, Hiroyuki Yoshitomi, Koichi Murata, Kosaku Murakami, Akira Onishi, Masao Tanaka, Shuichi Matsuda, Fumihiko Matsuda, Akio Morinobu, Motomu Hashimoto
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background The biological mechanisms underlying the differential response to abatacept in patients with rheumatoid arthritis (RA) are unknown. Here, we aimed to identify cellular, transcriptomic, and proteomic features that predict resistanc
Externí odkaz:
https://doaj.org/article/349a98cfe73040428b6ad347d65b135d
Autor:
Kosaku Murakami, Ryu Watanabe, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Motomu Hashimoto, Akio Morinobu
Publikováno v:
Immunological Medicine, Vol 47, Iss 1, Pp 45-51 (2024)
AbstractAbatacept (ABT) is a biological disease-modifying antirheumatic drug (bDMARDs) for rheumatoid arthritis (RA) when conventional synthetic DMARDs are ineffective. We aimed to evaluate the long-term effects of ABT on joint destruction in patient
Externí odkaz:
https://doaj.org/article/ba324496bec147d9996218b3323b7790
Autor:
Takayuki Fujii, Koichi Murata, Hideo Onizawa, Akira Onishi, Masao Tanaka, Kosaku Murakami, Kohei Nishitani, Moritoshi Furu, Ryu Watanabe, Motomu Hashimoto, Hiromu Ito, Takao Fujii, Tsuneyo Mimori, Akio Morinobu, Shuichi Matsuda
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Background Advances in rheumatoid arthritis (RA) treatment, highlighted by biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs), have altered the paradigm of RA treatment in the last decade. The
Externí odkaz:
https://doaj.org/article/2846f3a3312d4112a281842d9169b364
Autor:
Yoshikazu Fujikawa, Sho Sendo, Alfonso del Peral Fanjul, Hirotaka Yamada, Kenichi Uto, Yuzuru Yamamoto, Takumi Nagamoto, Akio Morinobu, Jun Saegusa
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMyeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells with immunosuppressive functions. It is known that MDSCs are expanded at inflammatory sites after migrating from bone marrow (BM) or spleen (Sp). In chronic i
Externí odkaz:
https://doaj.org/article/d1a23e26cd514993bbab3db12f2d7450
Autor:
Yoichi Nakayama, Ran Nakashima, Tomohiro Handa, Akihiro Ohsumi, Yoshito Yamada, Daisuke Nakajima, Yojiro Yutaka, Satona Tanaka, Satoshi Hamada, Kohei Ikezoe, Kiminobu Tanizawa, Mirei Shirakashi, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Hajime Yoshifuji, Hiroshi Date, Akio Morinobu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Advanced systemic sclerosis-associated interstitial lung disease (SSc-ILD) can be treated with lung transplantation. There is limited data on lung transplantation outcomes in patients with SSc-ILD, in non-Western populations.We assessed surv
Externí odkaz:
https://doaj.org/article/85ccd7fb150a4498a1c3d32962de9448
Autor:
Koji Kitagori, Takuma Oku, Masaki Wakabayashi, Tomoya Nakajima, Ran Nakashima, Kosaku Murakami, Yoshitaka Hirayama, Yasushi Ishihama, Koichiro Ohmura, Akio Morinobu, Tsuneyo Mimori, Hajime Yoshifuji
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-12 (2023)
Abstract Background Systemic lupus erythematosus (SLE) is an intractable disease characterized by autoantibody production and autoreactive B and T cell proliferation. Although several studies have revealed multiple genetic and environmental associati
Externí odkaz:
https://doaj.org/article/3a4fbfd45d8842a59803a9193c4e4429